TW200510447A - Novel fusidic acid derivatives - Google Patents

Novel fusidic acid derivatives

Info

Publication number
TW200510447A
TW200510447A TW093121380A TW93121380A TW200510447A TW 200510447 A TW200510447 A TW 200510447A TW 093121380 A TW093121380 A TW 093121380A TW 93121380 A TW93121380 A TW 93121380A TW 200510447 A TW200510447 A TW 200510447A
Authority
TW
Taiwan
Prior art keywords
acid derivatives
fusidic acid
novel
novel fusidic
infections
Prior art date
Application number
TW093121380A
Other languages
Chinese (zh)
Inventor
Tore Duvold
Laetitia Bouerat
Poul Rodbroe Rasmussen
Claus Aage Svensgaard Bretting
Jacob Thorhauge
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of TW200510447A publication Critical patent/TW200510447A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fusidic acid derivatives substituted at C-24 may be used in therapy for the treatment of infections.
TW093121380A 2003-07-16 2004-07-16 Novel fusidic acid derivatives TW200510447A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301080 2003-07-16
US48760903P 2003-07-17 2003-07-17
DKPA200301486 2003-10-09

Publications (1)

Publication Number Publication Date
TW200510447A true TW200510447A (en) 2005-03-16

Family

ID=34084106

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093121380A TW200510447A (en) 2003-07-16 2004-07-16 Novel fusidic acid derivatives

Country Status (6)

Country Link
KR (1) KR20060091290A (en)
IL (1) IL172699A0 (en)
IS (1) IS8301A (en)
MX (1) MXPA06000423A (en)
NO (1) NO20060614L (en)
TW (1) TW200510447A (en)

Also Published As

Publication number Publication date
IL172699A0 (en) 2006-04-10
NO20060614L (en) 2006-02-08
MXPA06000423A (en) 2006-04-05
KR20060091290A (en) 2006-08-18
IS8301A (en) 2006-02-14

Similar Documents

Publication Publication Date Title
AU2003220553A1 (en) Combination therapy for the treatment of conditions with pathogenic inflammatory components
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
TW200505881A (en) Tri(cyclo) substituted amide compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
IL172346A0 (en) Treatment of t cell mediated diseases by inhibition of fgfr3
UA85559C2 (en) Aminobenzophenone compounds
AU2003213768A1 (en) Use of benzimidazole analogs in the treatment of cell proliferation
GB0209891D0 (en) Novel compounds
DK1206474T3 (en) Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
NO20053042L (en) Use of spongosine (2-methoxyadenosine) for the treatment of pain, especially hyperalgesia.
TW200630367A (en) Substituted adenines and the uses thereof
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
MX2007010484A (en) Molecules and methods of using same for treating mcp-1/ccr2 associated diseases.
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
GB0416508D0 (en) Therapeutic agents
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
TW200508233A (en) Chk-1 inhibitors
IL177169A0 (en) Use of n- (2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
IL165562A0 (en) Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
GB0326633D0 (en) Therapeutic agents
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
MY140194A (en) Novel fusidic acid derivatives
PL371524A1 (en) Combination therapy for the treatment of bacterial infections